Sign In
CAVD Portal Log On
Log On Help
search
Home
The CAVD
The Research
The Grantees
About the CAVD
CAVD Structure
Collaborating Institutions
History of the CAVD
Legal Agreements
Young Investigators Recognition
About the Research
Progress in the CAVD
Publications
Conference Abstracts
Study Results
Gallo Vaccine Discovery Consortium
Greenberg Mouse Immunology Lab
Haynes Vaccine Discovery Consortium
Haynes Centralized Envelope Development Consortium
Ho Vaccine Discovery Consortium
Ho Ibalizumab Development Consortium
Koup Vaccine Immune Monitoring Consortium
Letvin Vaccine Discovery Consortium
McElrath Vaccine Discovery Consortium
Montefiori Vaccine Immune Monitoring Consortium
Pantaleo Vaccine Discovery Consortium
Pantaleo Poxvirus Vaccine Development Consortium
Parks Vaccine Discovery Consortium
Patterson Vaccine Discovery Consortium
Reinherz Vaccine Discovery Consortium
Self Vaccine Immunology Statistical Center
Stamatatos Vaccine Discovery Consortium
von Briesen HIV Specimen Cryorepository
Walker Vaccine Discovery Consortium
Weiss Vaccine Discovery Consortium
Wilson Vaccine Discovery Consortium
Zolla-Pazner Vaccine Discovery Consortium
Title
Comparison of HPLC/ESI-FTICR MS versus MALDI-TOF/TOF MS for glycopeptide analysis of a highly glycosylated HIV envelope glycoprotein.
Primary Author
Irungu, J
Authors
Irungu J, Go EP, Zhang Y, Dalpathado DS, Liao HX, Haynes BF, Desaire H.
CAVD Grantee
Haynes VDC
Journal Name
Journal of the American Society for Mass Spectrometry
Publication Date
8/1/2008
PubMed Search
Find in PubMed
Link to full-text
PMID
18565761
Abstract
Defining the structures and locations of the glycans attached on secreted proteins and virus envelope proteins is important in understanding how glycosylation affects their biological properties. Glycopeptide mass spectrometry (MS)-based analysis is a very powerful, emerging approach to characterize glycoproteins, in which glycosylation sites and the corresponding glycan structures are elucidated in a single MS experiment. However, to date there is not a consensus regarding which mass spectrometric platform provides the best glycosylation coverage information. Herein, we employ two of the most widely used MS approaches, online high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC/ESI-MS) and offline HPLC followed by matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS), to determine which of the two approaches provides the best glycosylation coverage information of a complex glycoprotein, the group M consensus HIV-1 envelope, CON-S gp140DeltaCFI, which has 31 potential glycosylation sites. Our results highlight differences in the informational content obtained between the two methods such as the overall number of glycosylation sites detected, the numbers of N-linked glycans present at each site, and the type of confirmatory information obtained about the glycopeptide using MS/MS experiments. The two approaches are quite complementary, both in their coverage of glycopeptides and in the information they provide in MS/MS experiments. The information in this study contributes to the field of mass spectrometry by demonstrating the strengths and limitations of two widely used MS platforms in glycoprotein analysis.
Was this publication authored by individuals from more than one CAVD Consortium?
No
Collaborating Consortia
Attachments
Created at 3/16/2009 11:53 AM by Hilda Villavicencio
Last modified at 3/16/2009 11:53 AM by Hilda Villavicencio
Use this page to add attachments to an item.
Name
© CAVD
Non-Member Access